{
    "mtblsStudy": {
        "studyStatus": "Public",
        "curationRequest": "MANUAL_CURATION",
        "modifiedTime": "2019-10-17T16:40:12.495000",
        "statusUpdateTime": "2019-10-17T16:40:12.495000",
        "read_access": true,
        "write_access": false,
        "is_curator": false
    },
    "isaInvestigation": {
        "comments": [
            {
                "name": "Created With Configuration",
                "value": "MetaboLightsConfig20150707"
            },
            {
                "name": "Last Opened With Configuration",
                "value": "MetaboLightsConfig20150707"
            }
        ],
        "identifier": "MTBLS1223",
        "title": "Investigation",
        "description": "",
        "submissionDate": "2019-09-11",
        "publicReleaseDate": "2019-10-17",
        "filename": "",
        "people": [],
        "publications": [],
        "ontologySourceReferences": [
            {
                "comments": [],
                "name": "OBI",
                "file": "http://data.bioontology.org/ontologies/OBI",
                "version": "29",
                "description": "Ontology for Biomedical Investigations"
            },
            {
                "comments": [],
                "name": "GO",
                "file": "http://data.bioontology.org/ontologies/GO",
                "version": "1557",
                "description": "Gene Ontology"
            },
            {
                "comments": [],
                "name": "MTBLS",
                "file": "https://www.ebi.ac.uk/metabolights/",
                "version": "1.0",
                "description": "User defined terms"
            },
            {
                "comments": [],
                "name": "BAO",
                "file": "http://data.bioontology.org/ontologies/BAO",
                "version": "26",
                "description": "BioAssay Ontology"
            },
            {
                "comments": [],
                "name": "CHMO",
                "file": "http://data.bioontology.org/ontologies/CHMO",
                "version": "18",
                "description": "Chemical Methods Ontology"
            },
            {
                "comments": [],
                "name": "EFO",
                "file": "http://data.bioontology.org/ontologies/EFO",
                "version": "146",
                "description": "Experimental Factor Ontology"
            },
            {
                "comments": [],
                "name": "MS",
                "file": "http://data.bioontology.org/ontologies/MS",
                "version": "129",
                "description": "Mass Spectrometry Ontology"
            },
            {
                "comments": [],
                "name": "NCIT",
                "file": "http://data.bioontology.org/ontologies/NCIT",
                "version": "44",
                "description": "National Cancer Institute Thesaurus"
            },
            {
                "comments": [],
                "name": "CHEBI",
                "file": "http://data.bioontology.org/ontologies/CHEBI",
                "version": "99",
                "description": "Chemical Entities of Biological Interest Ontology"
            },
            {
                "comments": [],
                "name": "BTO",
                "file": "http://data.bioontology.org/ontologies/BTO",
                "version": "29",
                "description": "BRENDA Tissue and Enzyme Source Ontology"
            }
        ],
        "studies": [
            {
                "comments": [],
                "identifier": "MTBLS1223",
                "filename": "s_MTBLS1223.txt",
                "title": "NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome (Intracellular UPLC-MS assay)",
                "description": "<p>Metabolic dysfunction is a primary feature of Werner syndrome (WS), a human premature aging disease caused by mutations in the gene encoding the Werner (WRN) DNA helicase. WS patients exhibit severe metabolic phenotypes, but the underlying mechanisms are not understood, and whether the metabolic deficit can be targeted for therapeutic intervention has not been determined. Here we report impaired mitophagy and depletion of NAD+, a fundamental ubiquitous molecule, in WS patient samples and WS invertebrate models. WRN regulates transcription of a key NAD+ biosynthetic enzyme nicotinamide nucleotide adenylyltransferase 1 (NMNAT1). NAD+ repletion restores NAD+ metabolic profiles and improves mitochondrial quality through DCT-1 and ULK-1-dependent mitophagy. At the organismal level, NAD+ repletion remarkably extends lifespan and delays accelerated aging, including stem cell dysfunction, in C. elegans and Drosophila melanogaster models of WS. Our findings suggest that accelerated aging in WRN syndrome is mediated by impaired mitochondrial function and mitophagy, and that bolstering cellular NAD+ levels counteracts WS phenotypes.</p><p><br></p><p><strong>Intracellular UPLC-MS</strong> assay protocols and data are reported in the current study <a href=https://www.ebi.ac.uk/metabolights/MTBLS1223 target=_blank><strong>MTBLS1223</strong></a>.</p><p><strong>Extracellular UPLC-MS</strong> assay protocols and data are reported in <a href=https://www.ebi.ac.uk/metabolights/MTBLS1221 target=_blank><strong>MTBLS1221</strong></a>.</p>",
                "submissionDate": "2019-09-11",
                "publicReleaseDate": "2019-10-17",
                "people": [
                    {
                        "comments": [],
                        "firstName": "Sofie",
                        "lastName": "Lautrup",
                        "email": "s.h.lautrup@medisin.uio.no",
                        "affiliation": "Post doctoral fellow",
                        "address": "Sykehusveien 25, Akershus University Hospital",
                        "fax": "",
                        "midInitials": "",
                        "phone": "+4550900938",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "http://data.bioontology.org/ontologies/NCIT",
                                    "version": "44",
                                    "description": "National Cancer Institute Thesaurus"
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C25936"
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Evandro",
                        "lastName": "Fang",
                        "email": "fei.fang@medisin.uio.no",
                        "affiliation": "Akershus University Hospital/University of Oslo, Norway",
                        "address": "Akershus University Hospital/University of Oslo, Norway",
                        "fax": "",
                        "midInitials": "Fei",
                        "phone": "",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "http://data.bioontology.org/ontologies/NCIT",
                                    "version": "44",
                                    "description": "National Cancer Institute Thesaurus"
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C25936"
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Vilhelm",
                        "lastName": "Bohr",
                        "email": "bohrv@grc.nia.nih.gov",
                        "affiliation": "National Institute on Aging",
                        "address": "National Institute on Aging, Bayview, Baltimore USA",
                        "fax": "",
                        "midInitials": "",
                        "phone": "",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Principal Investigator",
                                "termSource": {
                                    "comments": [],
                                    "name": "NCIT",
                                    "file": "http://data.bioontology.org/ontologies/NCIT",
                                    "version": "44",
                                    "description": "National Cancer Institute Thesaurus"
                                },
                                "termAccession": "http://purl.obolibrary.org/obo/NCIT_C19924"
                            }
                        ]
                    }
                ],
                "studyDesignDescriptors": [
                    {
                        "comments": [],
                        "annotationValue": "targeted metabolites",
                        "termSource": {
                            "comments": [],
                            "name": "MTBLS",
                            "file": "https://www.ebi.ac.uk/metabolights/",
                            "version": "1.0",
                            "description": "User defined terms"
                        },
                        "termAccession": "http://www.ebi.ac.uk/metabolights/ontology/MTBLS_000272"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Ultra-performance liquid chromatography-mass spectrometry",
                        "termSource": {
                            "comments": [],
                            "name": "CHMO",
                            "file": "http://data.bioontology.org/ontologies/CHMO",
                            "version": "18",
                            "description": "Chemical Methods Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHMO_0000715"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Werner syndrome",
                        "termSource": {
                            "comments": [],
                            "name": "EFO",
                            "file": "http://data.bioontology.org/ontologies/EFO",
                            "version": "146",
                            "description": "Experimental Factor Ontology"
                        },
                        "termAccession": "http://www.orpha.net/ORDO/Orphanet_902"
                    },
                    {
                        "comments": [],
                        "annotationValue": "NAD(+)",
                        "termSource": {
                            "comments": [],
                            "name": "CHEBI",
                            "file": "http://data.bioontology.org/ontologies/CHEBI",
                            "version": "99",
                            "description": "Chemical Entities of Biological Interest Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHEBI_15846"
                    },
                    {
                        "comments": [],
                        "annotationValue": "aging",
                        "termSource": {
                            "comments": [],
                            "name": "EFO",
                            "file": "http://data.bioontology.org/ontologies/EFO",
                            "version": "146",
                            "description": "Experimental Factor Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/GO_0007568"
                    },
                    {
                        "comments": [],
                        "annotationValue": "mitophagy",
                        "termSource": {
                            "comments": [],
                            "name": "GO",
                            "file": "http://data.bioontology.org/ontologies/GO",
                            "version": "1557",
                            "description": "Gene Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/GO_0000423"
                    },
                    {
                        "comments": [],
                        "annotationValue": "endometabolome",
                        "termSource": null,
                        "termAccession": ""
                    }
                ],
                "publications": [
                    {
                        "comments": [],
                        "title": "NAD(+) augmentation restores mitophagy and limits accelerated aging in Werner Syndrome",
                        "authorList": "Evandro F. Fang, Yujun Hou, Sofie Lautrup, Martin Borch Jensen, Beimeng Yang, Tanima SenGupta, Domenica Caponio, Rojyar Khezri, Tyler G. Demarest, Yahyah Aman, David Figueroa, Marya Morevati, Ho-Joon Lee, Hisaya Kato, Henok Kassahun, Jong-Hyuk Lee, Deborag L. Croteau, Yoshiro Maezawa, Costas A. Lyssiotis, Jun Tao, Koutaro Yokote, Tor Erik Rusten, Mark P. Mattson, Heinrich Jasper, Hilde Nilsen, Vilhelm A. Bohr",
                        "pubMedID": "",
                        "doi": "",
                        "status": {
                            "comments": [],
                            "annotationValue": "submitted",
                            "termSource": {
                                "comments": [],
                                "name": "MTBLS",
                                "file": "https://www.ebi.ac.uk/metabolights/",
                                "version": "1.0",
                                "description": "User defined terms"
                            },
                            "termAccession": "http://www.ebi.ac.uk/metabolights/ontology/placeholder"
                        }
                    }
                ],
                "factors": [
                    {
                        "comments": [],
                        "factorName": "Treatment",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "treatment",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "146",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000727"
                        }
                    },
                    {
                        "comments": [],
                        "factorName": "Genotype",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "genotype",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "146",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000513"
                        }
                    }
                ],
                "protocols": [
                    {
                        "comments": [],
                        "name": "Sample collection",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Sample collection",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>The primary fibroblast cell lines HT01 ( AG09599) and the WS01 ( AG03141) cells were acquired from Coriell Institute. The WRN-KD cells were siRNA knockdown in HT01 cells using WRN human siRNA ologo duplex (CAT : SR322215, Origene). Briefly, siRNAs were incubated in Optimem with 4 ml RNA Interferin (siRNA transfection reagent, Polyplus) per 1 ng RNA for 15 min and added to complete media for a final concentration of 30 nM siRNA. After 3-day incubation, cells were applied for further experiments. Knockdown efficiency was examined by western blot.</p><p><br></p><p>For intracellular NAD+ metabolites (including NMN, NAD+, NAAD, ADPR, MeNAM, NA, Inosine, IMP, NADP, cytidine, AMP, ADP, NAM etc.),</p><p>cells were treated with NAD+ precursor nicotinamide riboside (NR) for 24 h followed by collection of cells for LC-MS as detailed elsewhere[1]. Briefly, human primary fibroblasts where scraped in PBS and centrifuged, followed by removal of the supernatant and immediately frozen in liquid nitrogen before storage at -80 \u00b0C and shipment on dry ice. Samples of 3 biological repeats from primary human cell culture were used for the experiments (see Fig. 2 and Fig. S3 in the paper associated with this study).</p><p><br></p><p>Ref:</p><p>[1] Trammell SA, Weidemann BJ, Chadda A, Yorek MS, Holmes A, Coppey LJ, Obrosov A, Kardon RH, Yorek MA, Brenner C. Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Sci Rep. 2016 May 27;6:26933. doi:10.1038/srep26933. PMID:27230286</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Extraction",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Extraction",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Cell pellets were received on dry ice and stored at -80 \u00b0C. To extract metabolites both sets of internal standards were added along with 400 \u00b5l of hot ethanol/HEPES buffer as described previously, working 4 samples at a time. Extracted samples were stored on ice until all were complete. Samples were then heated at 55 \u00b0C with shaking for 3 min. Samples were centrifuged at 16.1 rcf, 4 \u00b0C. The supernatants were transferred to fresh microcentrifuge tubes. Calibrators and QC samples were prepared by adding both internal standards and both sets of calibrators to microcentrifuge tubes, 400 \u00b5l of hot ethanol/HEPES buffer was added and solvent for all samples, calibrators, and controls was removed in a vacuum centrifuge.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Post Extraction",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Derivatization",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Chromatography",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Chromatography",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Liquid chromatography-mass spectrometry (LC-MS)[1][2] was used.</p><p><br></p><p>For internal standards, stable isotope analogs of nucleotides and nucleoside were grown in a yeast broth with universally labelled 13C glucose, resulting in all ribose rings being fully labelled. NAAD is the only analyte of interest not having a labelled analog, 13C10 NAD was used as its internal standard. For the second analysis a mix of 18O-NR, 18O-Nam, d4-NA, d3-MeNam, and d3- methyl-4-pyridone-3-carboxamide was used as internal standard.</p><p><br></p><p>For LC-MS, the number of pmol of analytes in the samples were determined in 2 LCMS analyses, which were performed back to back. Separation and quantitation of analytes were performed with a Waters UPLC H-Class System interfaced with a TQD mass spectrometer (Waters) operated in positive ion multiple reaction monitoring mode. NAM related analytes were analyzed using an acid separation, whereas nucleotides and most nucleosides were analyzed using an alkaline separation, each using a dedicated 2.1 X 100 mm Hypercarb column (Thermo Fisher Scientific) held at 60 \u00b0C[3]. The autosampler was held at 8 \u00b0C.</p><p><br></p><p>Ref:</p><p>[1] Sousa CM, Biancur DE, Wang X, Halbrook CJ, Sherman MH, Zhang L, Kremer D, Hwang RF, Witkiewicz AK, Ying H, Asara JM, Evans RM, Cantley LC, Lyssiotis CA, Kimmelman AC. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016 Aug 25;536(7617):479-83. doi:10.1038/nature19084. PMID:27509858</p><p>[2] Trammell SA, Weidemann BJ, Chadda A, Yorek MS, Holmes A, Coppey LJ, Obrosov A, Kardon RH, Yorek MA, Brenner C. Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Sci Rep. 2016 May 27;6:26933. doi:10.1038/srep26933. PMID:27230286</p><p>[3] Trammell SA and Brenner C. Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites. Comput Struct Biotechnol J. 2013 May 27;4:e201301012. doi:10.5936/csbj.201301012. PMID:24688693</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Chromatography Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Autosampler model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column type",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Guard column",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Mass spectrometry",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Mass spectrometry",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Spectral data was collected on a Waters TQD mass spectrometer. The source temperature of the mass spectrometer was 150 \u00b0C and the desolvation temperature was 350 \u00b0C. Cone voltages and Collision energies were optimized for each MRM. The LC conditions for the NAM analysis were: Flow 0.20 ml/min, mobile phase 'C' 10 mM ammonium acetate + 0.1% formic acid; mobile phase 'D' acetonitrile + 0.1% formic acid. For the NAD run the flow rate was 0.353 ml/min, mobile phase 'C' 7.5 mM ammonium acetate + 0.05% ammonium hydroxide; mobile phase 'D' acetonitrile + 0.05% ammonium hydroxide. The gradients were for NAM were: mobile phase (D) was held at 5% for 1.8 min, increased to 40% in 11 min, then to 90% in 14.3 min and held for 0.1 min before going to initial condition and held for 5.6 min. The gradients were for NAD were: mobile phase (D) was held at 3% for 1.8 min, increased to 50% in 14 min, then to 90% in 16.2 min and held for 1 min before going to initial condition and held for 5 min.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan polarity",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan m/z range",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Ion source",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Mass analyzer",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Data transformation",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Data transformation",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Analytes were quantified in mol amounts using QuanLynx V4.1. These mol amounts were normalized to protein concentration of cell samples.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Metabolite identification",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Metabolite identification",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Metabolites were identified based on retention time and single reaction monitoring transition[1]. In enrichment experiments, metabolites were identified via retention time and mass (mass accuracy &lt;5 mDa).</p><p><br></p><p>Ref:</p><p>[1] Trammell SA, Brenner C. Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites. Comput Struct Biotechnol J. 2013 May;4(5). doi: 10.5936/csbj.201301012</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    }
                ],
                "assays": [
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "mass spectrometry",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "29",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000470"
                        },
                        "technologyPlatform": "Liquid Chromatography MS - positive - reverse phase",
                        "filename": "a_MTBLS1223_LC-MS_positive_reverse-phase_metabolite_profiling.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    }
                ],
                "sources": [],
                "samples": [],
                "processSequence": [],
                "characteristicCategories": [],
                "units": []
            }
        ]
    },
    "validation": {
        "errors": [],
        "warnings": []
    }
}